Design, Synthesis, and Biological Evaluation of 1,2,3-Triazole-Linked Triazino[5,6-B]Indole-Benzene Sulfonamide Conjugates as Potent Carbonic Anhydrase I, II, IX, and XIII Inhibitors

• Published in: Metabolites Vol. 10; no. 5; p. 200
• Main Authors: Chinchilli, Krishna Kartheek, Angeli, Andrea, Thacker, Pavitra S, Korra, Laxman Naik, Biswas, Rashmita, Arifuddin, Mohammed, Supuran, Claudiu T
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 15.05.2020; MDPI AG
• Subjects: 1,2,3-triazole; carbonic anhydrase inhibitors; triazino[5,6-b]indole-benzene sulfonamide; carbonic anhydrase inhibitors; triazino[5,6-b]indole-benzene sulfonamide; 1,2,3-triazole
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo10050200

A series of 1,2,3-triazole-linked triazino[5,6-b]indole-benzene sulfonamide hybrids (6a-6o) was synthesized and evaluated for carbonic anhydrase (CA, EC 4.2.1.1) inhibitory activity against the human (h) isoforms hCA I, II, XIII (cytosolic isoforms), and hCA IX (transmembrane tumor-associated isoform). The results revealed that the compounds exhibited K values in the low to medium nanomolar range against hCA II and hCA IX (K s ranging from 7.7 nM to 41.3 nM) and higher K values against hCA I and hCA XIII. Compound showed potent inhibition of hCA II (K = 7.7nM), being more effective compared to the standard inhibitor acetazolamide (AAZ) (K = 12.1 nM). Compounds and showed moderate activity against hCA XIII (K = 69.8 and 65.8 nM). Hence, compound could be consider as potential lead candidate for the design of potent and selective hCA II inhibitors.